Amanote Research
Register
Sign In
Pmh70 What Drove the Dramatic Slowdown in Psychiatric Drug Spending Growth in the United States
Value in Health
- United Kingdom
doi 10.1016/j.jval.2011.02.1094
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2011
Authors
T. Mark
Publisher
Elsevier BV
Related search
Insurance Coverage and the Heterogeneity of Health and Drug Spending in the United States
Geneva Papers on Risk and Insurance: Issues and Practice
Management
Finance
Business
Economics
Accounting
Econometrics
Psychiatric Court Clinics in the United States
Psychiatric Bulletin
Is This Time Different? The Slowdown in Healthcare Spending
Drug Reimportation Practices in the United States
Therapeutics and Clinical Risk Management
Chemical Health
Pharmacology
Safety
Medicine
Toxicology
Safety Research
Pharmaceutics
Dramatic Secular Changes in Prognosis for Kidney Transplant Candidates in the United States
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Cost Control in a Parallel Universe: Medicare Spending in the United States and Canada
Archives of Internal Medicine
Alcohol- And Drug-Involved Driving in the United States
Evaluation Review
Arts
Social Sciences
Humanities
Bridging Psychiatric and Anthropological Approaches: The Case of “Nerves” in the United States
Ethos
Anthropology
Arts
Sociology
Political Science
Humanities
What Really Happened to Consumption Inequality in the United States?
